Bactericidal activities of the cationic steroid CSA-13 and the cathelicidin peptide LL-37 against <it>Helicobacter pylori </it>in simulated gastric juice

Bactericidal activities of the cationic steroid CSA-13 and the cathelicidin peptide LL-37 against <it>Helicobacter pylori </it>in simulated gastric juice

<p>Abstract</p> <p>Background</p> <p>The worldwide appearance of drug-resistant strains of <it>H. pylori </it>motivates a search for new agents with therapeutic potential against this family of bacteria that colonizes the stomach, and is associated with aden...

Full description

Bibliographic Details
Main Authors:	Janmey Paul A, Diamond Scott, Savage Paul B, Namiot Zbigniew, Wen Qi, Fein David E, Namiot Andrzej, Leszczyńska Katarzyna, Bucki Robert
Format:	Article
Language:	English
Published:	BMC 2009-09-01
Series:	BMC Microbiology
Online Access:	http://www.biomedcentral.com/1471-2180/9/187

Similar Items

Formulation and candidacidal activity of magnetic nanoparticles coated with cathelicidin LL-37 and ceragenin CSA-13
by: Katarzyna Niemirowicz, et al.
Published: (2017-07-01)

Cathelicidin LL-37 in Health and Diseases of the Oral Cavity
by: Joanna Tokajuk, et al.
Published: (2022-05-01)

Anaerobic bacteria growth in the presence of cathelicidin LL-37 and selected ceragenins delivered as magnetic nanoparticles cargo
by: Bonita Durnaś, et al.
Published: (2017-07-01)

Candidacidal Activity of Selected Ceragenins and Human Cathelicidin LL-37 in Experimental Settings Mimicking Infection Sites.
by: Bonita Durnaś, et al.
Published: (2016-01-01)

Salivary Cathelicidin (LL-37) in Children and Adolescents Living with HIV
by: Ana Lucia Seminario, et al.
Published: (2024-01-01)

Bactericidal synergism between phage endolysin Ply2660 and cathelicidin LL-37 against vancomycin-resistant Enterococcus faecalis biofilms
by: Huihui Zhang, et al.
Published: (2023-04-01)

Efficacy of Cathelicidin LL-37 in an MRSA Wound Infection Mouse Model
by: Oriana Simonetti, et al.
Published: (2021-10-01)

Interactions of the human cathelicidin peptide LL-37 with DNA by biophysical methods.
by: Tan, Zhenwei.
Published: (2009)

Sphingosine-1-Phosphate-Triggered Expression of Cathelicidin LL-37 Promotes the Growth of Human Bladder Cancer Cells
by: Tomasz Wollny, et al.
Published: (2022-07-01)

The human cathelicidin LL-37 has antiviral activity against respiratory syncytial virus.
by: Silke M Currie, et al.
Published: (2013-01-01)

The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections
by: Ibrahim H. Babikir, et al.
Published: (2018-01-01)

The human cathelicidin antimicrobial peptide LL-37 and mimics are potential anticancer drugs
by: Kengo eKuroda, et al.
Published: (2015-06-01)

Significance and Diagnostic Role of Antimicrobial Cathelicidins (LL-37) Peptides in Oral Health
by: Zohaib Khurshid, et al.
Published: (2017-12-01)

Evaluating the Antiviral Activities of Human Cathelicidin LL-37 Peptide Against Rotavirus in Vitro
by: Zohreh Hosseini, et al.
Published: (2019-08-01)

Nanoantibiotics containing membrane-active human cathelicidin LL-37 or synthetic ceragenins attached to the surface of magnetic nanoparticles as novel and innovative therapeutic tools: current status and potential future applications
by: Urszula Wnorowska, et al.
Published: (2020-01-01)

Antimicrobial peptide LL-37 is bactericidal against Staphylococcus aureus biofilms.
by: Jason Kang, et al.
Published: (2019-01-01)

The Role of T Cells Reactive to the Cathelicidin Antimicrobial Peptide LL-37 in Acute Coronary Syndrome and Plaque Calcification
by: Fernando Chernomordik, et al.
Published: (2020-10-01)

Therapeutic Potential of Cathelicidin Peptide LL-37, an Antimicrobial Agent, in a Murine Sepsis Model
by: Isao Nagaoka, et al.
Published: (2020-08-01)

Retraction Note: Human cathelicidin LL-37 enhance the antibiofilm effect of EGCG on Streptococcus mutans
by: Yi-jie Guo, et al.
Published: (2017-06-01)

Cathelicidin LL-37 restoring glucocorticoid function in smoking and lipopolysaccharide-induced airway inflammation in rats
by: Jian-Zhen Weng, et al.
Published: (2019-03-01)

Citrullination Alters the Antiviral and Immunomodulatory Activities of the Human Cathelicidin LL-37 During Rhinovirus Infection
by: Víctor Casanova, et al.
Published: (2020-02-01)

The human cathelicidin antimicrobial peptide LL-37 as a potential treatment for polymicrobial infected wounds.
by: Allen J Duplantier, et al.
Published: (2013-07-01)

Core–shell magnetic nanoparticles display synergistic antibacterial effects against Pseudomonas aeruginosa and Staphylococcus aureus when combined with cathelicidin LL-37 or selected ceragenins
by: Niemirowicz K, et al.
Published: (2016-10-01)

Cathelicidin LL-37 promotes EMT, migration and metastasis of hepatocellular carcinoma cells in vitro and mouse model
by: Huidan Zhang, et al.
Published: (2023-12-01)

Antimicrobial peptide cathelicidin LL-37 preserves intestinal barrier and organ function in rats with heat stroke
by: Chih-Chin Shih, et al.
Published: (2023-05-01)

Antimicrobial cathelicidin peptide LL-37 inhibits the LPS/ATP-induced pyroptosis of macrophages by dual mechanism.
by: Zhongshuang Hu, et al.
Published: (2014-01-01)

Antiviral Activity of the Human Cathelicidin, LL-37, and Derived Peptides on Seasonal and Pandemic Influenza A Viruses.
by: Shweta Tripathi, et al.
Published: (2015-01-01)

Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37.
by: Peter G Barlow, et al.
Published: (2011-01-01)

Intralesional injection of vitamin D in verruca vulgaris increases cathelicidin (LL37) expression; therapeutic and immunohistochemical study
by: Neveen E. Sorour, et al.
Published: (2022-01-01)

Bactericidal Activity to <i>Escherichia coli</i>: Different Modes of Action of Two 24-Mer Peptides SAAP-148 and OP-145, Both Derived from Human Cathelicidine LL-37
by: Ayse Ön, et al.
Published: (2023-07-01)

The human cathelicidin peptide LL-37 inhibits pancreatic cancer growth by suppressing autophagy and reprogramming of the tumor immune microenvironment
by: Zhu Zhang, et al.
Published: (2022-07-01)

NDM-1 Carbapenemase-Producing Enterobacteriaceae are Highly Susceptible to Ceragenins CSA-13, CSA-44, and CSA-131
by: Chmielewska SJ, et al.
Published: (2020-09-01)

Epithelial-Immune Cell Crosstalk Determines the Activation of Immune Cells In Vitro by the Human Cathelicidin LL-37 at Low Physiological Concentrations
by: Ivan V. Bogdanov, et al.
Published: (2023-08-01)

Structure and Activity of a Selective Antibiofilm Peptide SK-24 Derived from the NMR Structure of Human Cathelicidin LL-37
by: Yingxia Zhang, et al.
Published: (2021-11-01)

Bactericidal Properties of Rod-, Peanut-, and Star-Shaped Gold Nanoparticles Coated with Ceragenin CSA-131 against Multidrug-Resistant Bacterial Strains
by: Sylwia Joanna Chmielewska, et al.
Published: (2021-03-01)

Influence of Vitamin D Deficiency on the Level of Salivary cathelicidin LL-37 in relation to Dental Caries Experience: A Case-Control Study
by: Narjes M. Alhelfi, et al.
Published: (2023-04-01)

Upregulating Human Cathelicidin Antimicrobial Peptide LL-37 Expression May Prevent Severe COVID-19 Inflammatory Responses and Reduce Microthrombosis
by: Karim M. Aloul, et al.
Published: (2022-05-01)

Sodium Butyrate Abrogates the Growth and Pathogenesis of Mycobacterium bovis via Regulation of Cathelicidin (LL37) Expression and NF-κB Signaling
by: Kai Zhang, et al.
Published: (2020-03-01)

Targeting polyelectrolyte networks in purulent body fluids to modulate bactericidal properties of some antibiotics
by: Bucki R, et al.
Published: (2018-01-01)

Nanomechanical Hallmarks of <i>Helicobacter pylori</i> Infection in Pediatric Patients
by: Piotr Deptuła, et al.
Published: (2021-05-01)